HIV-1 p24 Core, Human Immunodeficiency Virus Antigen, Recombinant
| Full Name |
HIV-1 p24 Core, Human Immunodeficiency Virus Antigen, Recombinant
|
Abbreviated Name-1 |
rHIV-Ip24c; HIVI p24 Core; HIV-1 p24 Core; HIV1 p24 Core |
| Documents |
| Figures |
| Reference |
|---|
Lazzarotto T, et al. An in vivo study on active cytomegalovirus infection in relation to active HIV replication in HIV-I infected drug addicts. J. Infect. May 1994; 28 (3): 287-291.
|
|
Description |
E. coli derived recombinant. GenScript Human Immunodeficiency Virus (HIV)-1 p24 Core contains the full length sequence of HIV-1 p24. |
Purity |
Protein is >95% pure (As determined by HPLC-C4, and 10% PAGE). |
Storage |
Reagent is shipped at ambient temperature. Freeze upon arrival. |
Concentration |
1 mg/ml in 50 mM Tris, pH 7.2, 8 M urea |
Stability |
Five years frozen. Six months in solution at 4°C. |
Specificity |
Immunoreactive with all sera of HIV-1 infected individuals |
Applications |
Antigen in ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems |
Note |
; |
Related Products
 |
1 |
Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 . |
2 |
Bacterial Expression System: GenScript has developed BacPowerTM technologies to tackle hard-to-express and hard-to-dissolve proteins. |
3 |
Yeast Expression System: GenScript's proprietary YeastHIGHTM technology combines the advantages of the bacterial and eukaryotic expression systems. |
4 |
Baculovirus/Insect Cell Expression System: GenScript developed BacuVanceTM platform for the secretion of recombinant proteins from baculovirus-infected insect cells. |
5 |
Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level. |
|